S2 E5: A Between the Biotech Waves Conversation with Kent Rogers

Today, I are excited to welcome Kent Rogers, the Chief Executive Officer of EveryONE Medicines. Kent brings a wealth of experience to his new role, having held executive leadership positions at renowned pharmaceutical companies as well as emerging biotech firms. With over 30 years of expertise in brand and generic pharmaceuticals, specialty pharmacy, and healthcare supply chain management, Kent has been at the forefront of developing disruptive solutions that enhance access to new medicines targeting critical disease states.
His leadership at EveryONE Medicines focuses on the research, development, and commercialization of individualized precision therapeutics, particularly for children facing rare and ultra-rare diseases. In addition to his role at EveryONE Medicines, Kent is a Venture Partner at ARCH Venture Partners and serves on the board of SlateRx, highlighting his commitment to advancing healthcare initiatives.
Join us as we discuss Kent's extensive career, his vision for EveryONE Medicines, and the innovative strategies he employs to create pathways for access to life-changing therapies. Whether you're a professional in the biotech field or just interested in the future of medicine, this episode promises to be insightful and inspiring.